Breaking News Bar

Business News and Information

Peninsula biotech with shot at MS drug to be sold for $3.7 billion

Partners since 2017, this South San Francisco company and its French counterpart agree on a deal that would pay shareholders $100 per share in cash.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear